Guofeng Li
Impact in
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds
- Biotechnology top 5%
- Transgenic Plants and Applications
Papers in
-
- Plant biochemistry and biosynthesis 10
- Plant tissue culture and regeneration 7
- Circular RNAs in diseases 6
- Cancer therapeutics and mechanisms 6
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 7
- Co-authors
- Hechun Ye (19 shared papers)Dahua Chen (1 shared paper)Benye Liu (7 shared papers)Hong Wang (6 shared papers)Zengchun Li (8 shared papers)Boxin Zhao (7 shared papers)Yabin Sun (5 shared papers)Ning Han (7 shared papers)
In The Last Decade
Guofeng Li
113 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 126
- Pharmacology 278
- Biotechnology 172
- Molecular Biology 1.3k
- Complementary and alternative medicine 132
- Cancer Research 222
Countries citing papers authored by Guofeng Li
This map shows the geographic impact of Guofeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Li more than expected).
Fields of papers citing papers by Guofeng Li
This network shows the impact of papers produced by Guofeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Li. The network helps show where Guofeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Guofeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 157 | |
| 2 | 2009 | 140 | |
| 3 | 2014 | 84 | |
| 4 | 2013 | 83 | |
| 5 | 2001 | 77 | |
| 6 | 2010 | 60 | |
| 7 | 2012 | 51 | |
| 8 | 2004 | 51 | |
| 9 | 2015 | 50 | |
| 10 | 2010 | 47 | |
| 11 | 2015 | 47 | |
| 12 | Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis. | 2015 | 47 |
| 13 | 2013 | 46 | |
| 14 | 2023 | 45 | |
| 15 | 2015 | 44 | |
| 16 | 2020 | 41 | |
| 17 | 2020 | 41 | |
| 18 | 2005 | 40 | |
| 19 | 2017 | 38 | |
| 20 | 2017 | 36 |
About Guofeng Li
Guofeng Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 121 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (10 papers), Plant biochemistry and biosynthesis (10 papers), MicroRNA in disease regulation (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Plant tissue culture and regeneration (7 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Pharmacology (278 citations), Biotechnology (172 citations), Molecular Biology (1.3k citations), Complementary and alternative medicine (132 citations) and Cancer Research (222 citations). Guofeng Li has collaborated with scholars based in China, Hong Kong and Japan. Frequent co-authors include Hechun Ye, Dahua Chen, Benye Liu, Hong Wang, Zengchun Li, Boxin Zhao, Yabin Sun, Ning Han, Fei Ren and Lanqing Ma. Their work appears in journals such as Frontiers in Pharmacology, Plant Science, PLoS ONE, Molecules and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.